Sign In
Buy AERI
$15.25
+0 (+0%)
At Close: Feb 17, 2023
Aerie Pharmaceuticals to Present at the Bank of America Securities 2020 Healthcare Conference
11:30am, Tuesday, 05'th May 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
Aerie Pharmaceuticals Inc (NASDAQ:AERI) Sees Large Increase in Short Interest
08:50am, Saturday, 02'nd May 2020
Aerie Pharmaceuticals Inc (NASDAQ:AERI) was the recipient of a significant increase in short interest in April. As of April 15th, there was short interest totalling 9,720,000 shares, an increase of 5.
Analysts' Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (LMAT), Aerie Pharma (AERI) and BioLife
Analysts’ Top Healthcare Picks: Lemaitre Vascular (LMAT), Aerie Pharma (AERI)
12:51pm, Friday, 01'st May 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lemaitre Vascular (
LMAT
–
Research Report
), Aerie Pharma (
AERI
–
Research Report
) and BioLife S
Global Ophthalmology Therapeutics Market (2020 to 2024) - Featuring AbbVie, Aerie Pharmaceuticals & Bayer Among Others
08:58am, Friday, 01'st May 2020
Dublin, May 01, 2020 -- The "Global Ophthalmology Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering. The author has.
Needham Maintains Buy on Aerie Pharmaceuticals, Lowers Price Target to $38
12:39pm, Thursday, 30'th Apr 2020Aerie Pharmaceuticals Inc (NASDAQ:AERI) Shares Sold by Cwm LLC
10:57am, Thursday, 30'th Apr 2020
Cwm LLC trimmed its holdings in Aerie Pharmaceuticals Inc (NASDAQ:AERI) by 4.2% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission
Needham Thinks Aerie Pharma's Stock is Going to Recover
09:52am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI) today and set a price target of $38.00. The company's shares closed last
Needham Thinks Aerie Pharma’s Stock is Going to Recover
09:52am, Thursday, 30'th Apr 2020
Needham analyst Serge Belanger maintained a Buy rating on Aerie Pharma (AERI – Research Report) today and set a price
Aerie Pharmaceuticals to Announce First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020
11:30am, Wednesday, 29'th Apr 2020
Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients wi
Aerie Pharmaceuticals (AERI) Expected to Beat Earnings Estimates: Should You Buy?
04:34pm, Tuesday, 28'th Apr 2020
Aerie (AERI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aerie Pharmaceuticals (AERI) Expected to Beat Earnings Estimates: Should You Buy?
04:34pm, Tuesday, 28'th Apr 2020
Aerie (AERI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Insights on the Worldwide Ophthalmology Therapeutics Industry to 2024 - Key Drivers and Challenges - ResearchAndMarkets.com
12:58pm, Tuesday, 28'th Apr 2020
The "Global Ophthalmology Therapeutics Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
Crispr Therapeutics (NASDAQ:CRSP) vs. Aerie Pharmaceuticals (NASDAQ:AERI) Head-To-Head Contrast
05:44am, Tuesday, 28'th Apr 2020
Crispr Therapeutics (NASDAQ:CRSP) and Aerie Pharmaceuticals (NASDAQ:AERI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of t
